About
Back
About IPL
Management Team
Board of Directors
Pipeline
Therapeutic Areas
Clinical Trials
Technology
News & Publications
Back
Press Releases
Media
Publications
Contact
We're Making News
ALS News Today: IPL344 slows ALS progression in trial, data suggest
Read Full Article
© 2025 Immunity Pharma Ltd.
LiveSites